Skip to content

a comparative clinical study of erandbeejadi gutika pippalyadi gana kashaya and ruksha pottali sweda in the management of amavata

a comparative clinical study to evaluate the efficacy of erandbeejadi gutika pippalyadi gana kashaya and ruksha pottali sweda in the management of amavata

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049968
Enrollment
60
Registered
2023-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Department of Kayachikitsa Shri Narayan Prasad Awasthi Govt. Ayurved College Raipur CHHATTISGARH
Lead Sponsor
Department of Kayachikitsa Shri Narayan Prasad Awasthi Govt Ayurved College Raipur CHHATTISGARH
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: it is based on Clinical signs and symptoms mentioned in ayurvedic and modern classics, especially pain swelling, and stiffness. Health Assessment Questionnaire for RA Visual Analog Scale (VAS) WOMAC Index

Exclusion criteria

Exclusion criteria: 1. Patients below 18 years and above 60 years of age will not be taken. 2. Patients who develop a secondary complication of RA e.g. pleuro-pericardial disease. severely damaged joint with bedridden patients and severe crippling deformities. 3. Patients having neoplasm of the spine, gout, ankylosing spondylitis, traumatic arthritis, and pyogenic osteomyelitis. 4. Patients suffering from paralysis, Liver cirrhosis, Liver failure, Hepatocellular or any carcinoma, and Ascites. 5. Patients having associated cardiac disease, pulmonary tuberculosis, uncontrolled diabetes mellitus, malignant hypertension, renal function impairment, etc. 6. Pregnant and lactating mother. 7. Patients who are taken steroids. 8. Other joint disorders like Gout, Osteoarthritis. The patient mentioned above who is suffering from any severe disease will come under the category of exclusion.

Design outcomes

Primary

MeasureTime frame
reduce the symptoms of amavata especially pain,swelling and stiffness(rheumatoid arthritis)Timepoint: reduce the symptoms of amavata in 8 weeks

Secondary

MeasureTime frame
improve the quality of lifeTimepoint: 90 days

Countries

India

Contacts

Public ContactDrRashmi Diwan

Shri Narayana Prasad Awasthi Government Ayurved College Raipur CHHATTISGARH

arunaojha90@gmail.com9424401858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026